Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-28

Clinical Trial Update: Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating inhaled RNS60 in combination with budesonide for mild-to-moderate asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)
  • RNS60

Snippet

Sponsor: Revalesio Corporation | Conditions: Asthma | Phase 1 | Status: COMPLETED